Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

Vulnerable and elderly Australians are missing out on protection against respiratory syncytial virus (RSV) because many can’t ...

As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, with health experts warning ...

UPMC saw an increase in RSV cases in its health system, including in Lancaster County, a spokesperson said Jan. 7, especially ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

U.S. surges of COVID-19, influenza, respiratory syncytial virus (RSV) and norovirus have collectively been dubbed a ...

With rising cases of flu, COVID, RSV, and norovirus, older adults must take essential precautions to stay safe during the ...

Effective immediately, only two people are permitted at the bedside of patients during the day and one person overnight at ...

Respiratory syncytial virus (RSV) leads to over 30 million severe respiratory infections, 3.5 million hospitalizations, and 100,000 deaths among children under five each year globally. Nearly half of ...

Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the ...

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during ...